Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
- B1943 Fenofibrate1 CitationSummary: PPARα agonist
- B1947 GemfibrozilSummary: PPARα activator
- B3610 ClofibrateSummary: PPAR agonist
- B7010 15-deoxy-Δ-12,14-Prostaglandin J2Target: PPARSummary: PPARγ agonist
- B6681 CiglitazoneSummary: PPARγ agonist
- B6691 BADGESummary: PPARγ antagonist
- B6826 GW 7647Summary: PPARα agonist
- B6929 SR 202Summary: PPAR antagonist
- B7406 GSK 0660Summary: PPARδ antagonist
- B7471 S26948Summary: PPARγ agonist